0001236031-18-000024.txt : 20180605
0001236031-18-000024.hdr.sgml : 20180605
20180605133645
ACCESSION NUMBER: 0001236031-18-000024
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180601
FILED AS OF DATE: 20180605
DATE AS OF CHANGE: 20180605
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KERSTEN GEERT R
CENTRAL INDEX KEY: 0001236030
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11889
FILM NUMBER: 18880648
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEL SCI CORP
CENTRAL INDEX KEY: 0000725363
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 840916344
STATE OF INCORPORATION: CO
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 8229 BOONE BLVD .
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
BUSINESS PHONE: 7035069460
MAIL ADDRESS:
STREET 1: 8229 BOONE BLVD.
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
FORMER COMPANY:
FORMER CONFORMED NAME: INTERLEUKIN 2 INC
DATE OF NAME CHANGE: 19880317
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2018-06-01
0
0000725363
CEL SCI CORP
cvm
0001236030
KERSTEN GEERT R
1
1
0
0
Chief Executive Officer
Common Stock
2018-06-01
4
X
0
14760
1.75
A
505024
D
Series S Warrants
1.75
2018-06-01
4
X
0
369000
132795
D
2013-10-11
2018-10-11
Common Stock
14760
1611562
D
Geert Kersten
2018-06-05